心臓ワークステーションの市場規模、シェア、動向分析レポート：用途別、流通チャネル別、地域別、セグメント予測、2025年～2030年

心臓ワークステーションの市場規模と動向

心臓ワークステーションの世界市場規模は、2024年に3億6,326万米ドルと推定され、2025～2030年にかけてCAGR 9.10％で成長すると予測されています。

心臓ワークステーション市場は、心血管疾患の有病率の上昇、心電図（ECG）手技の増加、心臓疾患にかかりやすい高齢者の増加によって牽引されています。オックスFord大学出版局が2024年11月に発表したデータによると、世界中で年間3億件以上のECGが実施されています。

心血管疾患の罹患率の上昇は、心臓ワークステーション市場を大きく牽引しています。2025年1月にJournal of Cardiac Failure誌に発表されたデータによると、現在アメリカに住む20歳以上の心不全患者は約670万人です。この数は予測期間中に70％増加すると予測されており、心血管疾患の負担が増大していることを裏付けています。2030年、2040年、2050年の心不全発生率を下図に示します。心不全の発生率が上昇するにつれて、心臓ワークステーションのような先進的診断・モニタリングツールに対する需要が高まっています。

さらに、米国心臓協会による2024年心臓病・脳卒中統計アップデートによると、2021年に死亡した93万1,578人の根本的な原因は心血管系疾患であり、すべてのがんと慢性呼吸器疾患の合計による死亡を上回っています。この憂慮すべき統計は、心血管系疾患のタイムリーな診断と効率的な管理が極めて重要であることを浮き彫りにしています。その結果、包括的な心血管評価をサポートし、臨床ワークフローを合理化する心臓ワークステーションの需要が大幅に伸びています。

さらに、世界中で心疾患の負担が増加しているため、心電図検査の件数も大幅に増加しています。米国だけでも年間1億件以上の12誘導心電図検査が実施されており、心疾患を検出するための最も一般的な診断ツールとなっています。また、2023年2月にGEヘルスケアが発表した記事によると、急性期医療と外来の両方で、世界全体で毎年3億件以上の心電図検査が実施されています。このように、年間3億件以上の心電図検査が実施されていることから、ワークフローを合理化し、診断精度を向上させ、効果的な心臓治療に対する需要の高まりに対応する心臓ワークステーションの需要が高まると予想されます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 心臓ワークステーション市場の変数、動向、範囲

• 市場系統の展望
  • 親市場の展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
  • 市場機会分析
  • 市場課題分析
• 心臓ワークステーション市場分析ツール
  • 産業分析-ポーターのファイブフォース分析
  • PESTEL分析

第4章 心臓ワークステーション市場：最終用途別、推定・動向分析

• セグメントダッシュボード
• 世界の心臓ワークステーション市場の変動分析
• 世界の心臓ワークステーション市場規模と動向分析（最終用途別、2018～2030年）
• 病院
  • 病院市場推定・予測、2018～2030年
• 外来手術センター
  • 外来手術センター市場推定・予測、2018～2030年
• 医院/専門クリニック/オフィスベースの検査室
  • 医院/専門クリニック/オフィスベースの検査市場推定・予測、2018～2030年
• 高度看護施設
  • 高度看護施設市場推定・予測、2018～2030年
• その他
  • その他市場推定・予測、2018～2030年

第5章 心臓ワークステーション市場：流通チャネル別、推定・動向分析

• セグメントダッシュボード
• 世界の心臓ワークステーション市場の変動分析
• 世界の心臓ワークステーション市場規模と動向分析（流通チャネル別、2018～2030年）
• 医療サージ配布
• IT/CDW/VAR（付加価値再販業者）

第6章 心臓ワークステーション市場：地域別、推定・動向分析

• 地域ダッシュボード
• 市場規模と予測と動向分析、2018～2030年
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • 日本
  • インド
  • 中国
  • 韓国
  • オーストラリア
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第7章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 企業/競合の分類
  • イノベーター
• ベンダー情勢
  • 主要販売代理店とチャネルパートナー一覧
• 2024年の世界主要企業の市場シェア分析
  • Koninklijke Philips N.V
  • GE HealthCare
  • Baxter (Hillrom Services, Inc.)
  • AFC Industries, Inc.
  • SCHILLER AG
  • EDAN Instruments, Inc.
  • Medtronic
  • CONTEC MEDICAL SYSTEMS CO.,LTD
  • Lepu Medical Technology(Beijing)Co.,Ltd.
  • Cardioline S.P.A.
• ヒートマップ分析/企業市況分析
• 2024年の企業市場シェア予測分析
• その他の主要市場参入企業一覧

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviation
• Table 3 North America cardiac workstation market, by country, 2018 - 2030 (USD Million)
• Table 4 North America cardiac workstation market, by end use, 2018 - 2030 (USD Million)
• Table 5 North America cardiac workstation market, by distribution channel, 2018 - 2030 (USD Million)
• Table 6 U.S. cardiac workstation market, by end use, 2018 - 2030 (USD Million)
• Table 7 U.S. cardiac workstation market, by distribution channel, 2018 - 2030 (USD Million)
• Table 8 Canada cardiac workstation market, by end use, 2018 - 2030 (USD Million)
• Table 9 Canada cardiac workstation market, by distribution channel, 2018 - 2030 (USD Million)
• Table 10 Mexico cardiac workstation market, by end use, 2018 - 2030 (USD Million)
• Table 11 Mexico cardiac workstation market, by distribution channel, 2018 - 2030 (USD Million)
• Table 12 Europe cardiac workstation market, by country, 2018 - 2030 (USD Million)
• Table 13 Europe cardiac workstation market, by end use, 2018 - 2030 (USD Million)
• Table 14 Europe cardiac workstation market, by distribution channel, 2018 - 2030 (USD Million)
• Table 15 UK cardiac workstation market, by end use, 2018 - 2030 (USD Million)
• Table 16 UK cardiac workstation market, by distribution channel, 2018 - 2030 (USD Million)
• Table 17 Germany cardiac workstation market, by end use, 2018 - 2030 (USD Million)
• Table 18 Germany cardiac workstation market, by distribution channel, 2018 - 2030 (USD Million)
• Table 19 France cardiac workstation market, by end use, 2018 - 2030 (USD Million)
• Table 20 France cardiac workstation market, by distribution channel, 2018 - 2030 (USD Million)
• Table 21 Italy cardiac workstation market, by end use, 2018 - 2030 (USD Million)
• Table 22 Italy cardiac workstation market, by distribution channel, 2018 - 2030 (USD Million)
• Table 23 Spain cardiac workstation market, by end use, 2018 - 2030 (USD Million)
• Table 24 Spain cardiac workstation market, by distribution channel, 2018 - 2030 (USD Million)
• Table 25 Denmark cardiac workstation market, by end use, 2018 - 2030 (USD Million)
• Table 26 Denmark cardiac workstation market, by distribution channel, 2018 - 2030 (USD Million)
• Table 27 Sweden cardiac workstation market, by end use, 2018 - 2030 (USD Million)
• Table 28 Sweden cardiac workstation market, by distribution channel, 2018 - 2030 (USD Million)
• Table 29 Norway cardiac workstation market, by end use, 2018 - 2030 (USD Million)
• Table 30 Norway cardiac workstation market, by distribution channel, 2018 - 2030 (USD Million)
• Table 31 Asia Pacific cardiac workstation market, by country, 2018 - 2030 (USD Million)
• Table 32 Asia Pacific cardiac workstation market, by end use, 2018 - 2030 (USD Million)
• Table 33 Asia Pacific cardiac workstation market, by distribution channel, 2018 - 2030 (USD Million)
• Table 34 China cardiac workstation market, by end use, 2018 - 2030 (USD Million)
• Table 35 China cardiac workstation market, by distribution channel, 2018 - 2030 (USD Million)
• Table 36 Japan cardiac workstation market, by end use, 2018 - 2030 (USD Million)
• Table 37 Japan cardiac workstation market, by distribution channel, 2018 - 2030 (USD Million)
• Table 38 India cardiac workstation market, by end use, 2018 - 2030 (USD Million)
• Table 39 India cardiac workstation market, by distribution channel, 2018 - 2030 (USD Million)
• Table 40 South Korea cardiac workstation market, by end use, 2018 - 2030 (USD Million)
• Table 41 South Korea cardiac workstation market, by distribution channel, 2018 - 2030 (USD Million)
• Table 42 Australia cardiac workstation market, by end use, 2018 - 2030 (USD Million)
• Table 43 Australia cardiac workstation market, by distribution channel, 2018 - 2030 (USD Million)
• Table 44 Thailand cardiac workstation market, by end use, 2018 - 2030 (USD Million)
• Table 45 Thailand cardiac workstation market, by distribution channel, 2018 - 2030 (USD Million)
• Table 46 Latin America cardiac workstation market, by country, 2018 - 2030 (USD Million)
• Table 47 Latin America cardiac workstation market, by end use, 2018 - 2030 (USD Million)
• Table 48 Latin America cardiac workstation market, by distribution channel, 2018 - 2030 (USD Million)
• Table 49 Brazil cardiac workstation market, by end use, 2018 - 2030 (USD Million)
• Table 50 Brazil cardiac workstation market, by distribution channel, 2018 - 2030 (USD Million)
• Table 51 Mexico cardiac workstation market, by end use, 2018 - 2030 (USD Million)
• Table 52 Mexico cardiac workstation market, by distribution channel, 2018 - 2030 (USD Million)
• Table 53 Argentina cardiac workstation market, by end use, 2018 - 2030 (USD Million)
• Table 54 Argentina cardiac workstation market, by distribution channel, 2018 - 2030 (USD Million)
• Table 55 Middle East & Africa cardiac workstation market, by country, 2018 - 2030 (USD Million)
• Table 56 Middle East & Africa cardiac workstation market, by end use, 2018 - 2030 (USD Million)
• Table 57 Middle East & Africa cardiac workstation market, by distribution channel, 2018 - 2030 (USD Million)
• Table 58 South Africa cardiac workstation market, by end use, 2018 - 2030 (USD Million)
• Table 59 South Africa cardiac workstation market, by distribution channel, 2018 - 2030 (USD Million)
• Table 60 Saudi Arabia cardiac workstation market, by end use, 2018 - 2030 (USD Million)
• Table 61 Saudi Arabia cardiac workstation market, by distribution channel, 2018 - 2030 (USD Million)
• Table 62 UAE cardiac workstation market, by end use, 2018 - 2030 (USD Million)
• Table 63 UAE cardiac workstation market, by distribution channel, 2018 - 2030 (USD Million)
• Table 64 Kuwait cardiac workstation market, by end use, 2018 - 2030 (USD Million)
• Table 65 Kuwait cardiac workstation market, by distribution channel, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Information Procurement
• Fig. 2 Primary Research Pattern
• Fig. 3 Market Research Approaches
• Fig. 4 Value Chain-Based Sizing & Forecasting
• Fig. 5 Market Formulation & Validation
• Fig. 6 Cardiac Workstation Market, Market Segmentation
• Fig. 7 Market Driver Analysis (Current & Future Impact)
• Fig. 8 Market Restraint Analysis (Current & Future Impact)
• Fig. 9 Market Opportunity Analysis (Current & Future Impact)
• Fig. 10 Market Challenge Analysis (Current & Future Impact)
• Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• Fig. 12 Porter's Five Forces Analysis
• Fig. 13 Regional Marketplace: Key Takeaways
• Fig. 14 Global Cardiac Workstation Market, for End Use, 2018 - 2030 (USD Million)
• Fig. 15 Global Cardiac Workstation Market, for Hospitals, 2018 - 2030 (USD Million)
• Fig. 16 Global Cardiac Workstation Market, for Ambulatory Surgery Centers, 2018 - 2030 (USD Million)
• Fig. 17 Global Cardiac Workstation Market, for Physician Offices/ Specialty Clinics/ Office Based Labs, 2018 - 2030 (USD Million)
• Fig. 18 Global Cardiac Workstation Market, for Skilled Nursing Facilities, 2018 - 2030 (USD Million)
• Fig. 19 Global Cardiac Workstation Market, for Others, 2018 - 2030 (USD Million)
• Fig. 20 Global Cardiac Workstation Market, for Distribution Channel, 2018 - 2030 (USD Million)
• Fig. 21 Global Cardiac Workstation Market, for Medical Surge Distribution, 2018 - 2030 (USD Million)
• Fig. 22 Global Cardiac Workstation Market, for IT/ CDW/ VAR-Value Added Reseller, 2018 - 2030 (USD Million)
• Fig. 23 Regional Outlook, 2024 & 2030
• Fig. 24 North America Cardiac Workstation Market, 2018 - 2030 (USD Million)
• Fig. 25 U.S. Cardiac Workstation Market, 2018 - 2030 (USD Million)
• Fig. 26 Canada Cardiac Workstation Market, 2018 - 2030 (USD Million)
• Fig. 27 Mexico Cardiac Workstation Market, 2018 - 2030 (USD Million)
• Fig. 28 Europe Cardiac Workstation Market, 2018 - 2030 (USD Million)
• Fig. 29 Germany Cardiac Workstation Market, 2018 - 2030 (USD Million)
• Fig. 30 UK Cardiac Workstation Market, 2018 - 2030 (USD Million)
• Fig. 31 France Cardiac Workstation Market, 2018 - 2030 (USD Million)
• Fig. 32 Italy Cardiac Workstation Market, 2018 - 2030 (USD Million)
• Fig. 33 Spain Cardiac Workstation Market, 2018 - 2030 (USD Million)
• Fig. 34 Denmark Cardiac Workstation Market, 2018 - 2030 (USD Million)
• Fig. 35 Sweden Cardiac Workstation Market, 2018 - 2030 (USD Million)
• Fig. 36 Norway Cardiac Workstation Market, 2018 - 2030 (USD Million)
• Fig. 37 Asia Pacific Cardiac Workstation Market, 2018 - 2030 (USD Million)
• Fig. 38 Japan Cardiac Workstation Market, 2018 - 2030 (USD Million)
• Fig. 39 China Cardiac Workstation Market, 2018 - 2030 (USD Million)
• Fig. 40 India Cardiac Workstation Market, 2018 - 2030 (USD Million)
• Fig. 41 Australia Cardiac Workstation Market, 2018 - 2030 (USD Million)
• Fig. 42 South Korea Cardiac Workstation Market, 2018 - 2030 (USD Million)
• Fig. 43 Thailand Cardiac Workstation Market, 2018 - 2030 (USD Million)
• Fig. 44 Latin America Cardiac Workstation Market, 2018 - 2030 (USD Million)
• Fig. 45 Brazil Cardiac Workstation Market, 2018 - 2030 (USD Million)
• Fig. 46 Argentina Cardiac Workstation Market, 2018 - 2030 (USD Million)
• Fig. 47 Middle East and Africa Cardiac Workstation Market, 2018 - 2030 (USD Million)
• Fig. 48 South Africa Cardiac Workstation Market, 2018 - 2030 (USD Million)
• Fig. 49 Saudi Arabia Cardiac Workstation Market, 2018 - 2030 (USD Million)
• Fig. 50 UAE Cardiac Workstation Market, 2018 - 2030 (USD Million)
• Fig. 51 Kuwait Cardiac Workstation Market, 2018 - 2030 (USD Million)

Cardiac Workstation Market Size & Trends:

The global cardiac workstation market size was estimated at USD 363.26 million in 2024 and is projected to grow at a CAGR of 9.10% from 2025 to 2030. The cardiac workstation market is driven by the rising prevalence of cardiovascular diseases, increasing electrocardiogram (ECG) procedures, and the growing geriatric population, which is more susceptible to heart conditions. According to the data published by the Oxford University Press in November 2024, over 300 million ECGs are performed annually across the globe.

The rising incidence of cardiovascular diseases significantly drives the cardiac workstation market. According to the data published in the Journal of Cardiac Failure in January 2025, about 6.7 million individuals living in America over the age of 20 currently live with heart failure. This number is projected to increase by 70% over the forecast period, underscoring the growing burden of cardiovascular conditions. The incidence of heart failure in 2030, 2040, and 2050 is represented in the figure below. As the incidence of heart failure rises, there is a growing demand for advanced diagnostic and monitoring tools, such as cardiac workstations.

Moreover, according to the 2024 Heart Disease and Stroke Statistics Update by the American Heart Association, cardiovascular disease was the underlying cause of 931,578 deaths in the U.S. in 2021-surpassing deaths from all forms of cancer and chronic lower respiratory diseases combined. This alarming statistic highlights the critical need for timely diagnosis and efficient management of cardiovascular conditions. As a result, the demand for cardiac workstations, which support comprehensive cardiovascular assessment and streamline clinical workflows, is witnessing substantial growth.

In addition, due to the growing burden of cardioavcular diseases across the globe, the number of ECG procedures is also increasing significantly. In the U.S. alone, over 100 million 12-lead ECGs are performed annually, making it the most commonly used diagnostic tool for detecting heart disease. Also, as per the data published in GE HealthCare's article in February 2023, more than 300 million ECGs are conducted each year globally across both acute care and ambulatory settings. Thus, the extensive need and large number of ECG procedures undertaken yearly are anticipated to boost the demand for cardiac workstations to streamline workflows, improve diagnostic precision, and meet the growing demand for effective cardiac care.

Global Cardiac Workstation Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global cardiac workstation market report on the basis of end-use, distribution channel, and region

• End-use Outlook (Revenue, USD Million, 2018 - 2030)
• Hospitals
• Ambulatory Surgical Centers
• Physician Offices/ Specialty Clinics/ Office Based Labs
• Skilled Nursing Facilities
• Others
• Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
• Medical Surge Distribution
• IT/ CDW/ VAR-Value Added Reseller
• Regional Outlook (Revenue, USD Million, 2018 - 2030)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Content

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. End Use
  • 1.1.2. Distribution Channel
  • 1.1.3. Regional scope
  • 1.1.4. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.6.2. Volume price analysis (Model 2)
    • 1.6.2.1. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives
  • 1.9.1. Objective 1
  • 1.9.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Cardiac Workstation Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing prevalence of cardiac disorders
    • 3.2.1.2. Rising number of ECG procedures
    • 3.2.1.3. Introduction of innovative and advanced products
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Lack of awareness in some regions
    • 3.2.2.2. High treatment costs
  • 3.2.3. Market opportunity analysis
    • 3.2.3.1. Improvements in public and private hospital infrastructure
    • 3.2.3.2. Growth potential in emerging economies in cardiac workstation market
  • 3.2.4. Market challenge analysis
    • 3.2.4.1. Product recalls
• 3.3. Cardiac Workstation Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape

Chapter 4. Cardiac Workstation Devices: End Use Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Cardiac Workstation Market Movement Analysis
• 4.3. Global Cardiac Workstation Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 4.4. Hospitals
  • 4.4.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
• 4.5. Ambulatory Surgery Centers
  • 4.5.1. Ambulatory surgery centers market estimates and forecast 2018 to 2030 (USD Million)
• 4.6. Physician Offices/ Specialty Clinics/ Office Based Labs
  • 4.6.1. Physician offices/ specialty clinics/ office based labs market estimates and forecast 2018 to 2030 (USD Million)
• 4.7. Skilled Nursing Facilities
  • 4.7.1. Skilled nursing facilities market estimates and forecast 2018 to 2030 (USD Million)
• 4.8. Others
  • 4.8.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Cardiac Workstation Market: Distribution Channel Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Cardiac Workstation Market Movement Analysis
• 5.3. Global Cardiac Workstation Market Size & Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
• 5.4. Medical Surge Distribution
  • 5.4.1. Medical surge distribution market estimates and forecast 2018 to 2030 (USD Million)
• 5.5. IT/ CDW/ VAR-(Value Added Reseller)
  • 5.5.1. IT/ CDW/ VAR-(Value Added Reseller) market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Cardiac Workstation Market: Regional Estimates & Trend Analysis

• 6.1. Regional Dashboard
• 6.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
• 6.3. North America
  • 6.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 6.3.2. U.S.
    • 6.3.2.1. Key country dynamics
    • 6.3.2.2. Competitive scenario
    • 6.3.2.3. Regulatory framework
    • 6.3.2.4. Reimbursement scenario
    • 6.3.2.5. U.S. market estimates and forecasts, 2018 - 2030
  • 6.3.3. Canada
    • 6.3.3.1. Key country dynamics
    • 6.3.3.2. Competitive scenario
    • 6.3.3.3. Regulatory framework
    • 6.3.3.4. Reimbursement scenario
    • 6.3.3.5. Canada market estimates and forecasts, 2018 - 2030
  • 6.3.4. Mexico
    • 6.3.4.1. Key country dynamics
    • 6.3.4.2. Competitive scenario
    • 6.3.4.3. Regulatory framework
    • 6.3.4.4. Reimbursement scenario
    • 6.3.4.5. Mexico market estimates and forecasts, 2018 - 2030
• 6.4. Europe
  • 6.4.1. UK
    • 6.4.1.1. Key country dynamics
    • 6.4.1.2. Competitive scenario
    • 6.4.1.3. Regulatory framework
    • 6.4.1.4. Reimbursement scenario
    • 6.4.1.5. UK market estimates and forecasts, 2018 - 2030
  • 6.4.2. Germany
    • 6.4.2.1. Key country dynamics
    • 6.4.2.2. Competitive scenario
    • 6.4.2.3. Regulatory framework
    • 6.4.2.4. Reimbursement scenario
    • 6.4.2.5. Germany market estimates and forecasts, 2018 - 2030
  • 6.4.3. France
    • 6.4.3.1. Key country dynamics
    • 6.4.3.2. Competitive scenario
    • 6.4.3.3. Regulatory framework
    • 6.4.3.4. Reimbursement scenario
    • 6.4.3.5. France market estimates and forecasts, 2018 - 2030
  • 6.4.4. Italy
    • 6.4.4.1. Key country dynamics
    • 6.4.4.2. Competitive scenario
    • 6.4.4.3. Regulatory framework
    • 6.4.4.4. Reimbursement scenario
    • 6.4.4.5. Italy market estimates and forecasts, 2018 - 2030
  • 6.4.5. Spain
    • 6.4.5.1. Key country dynamics
    • 6.4.5.2. Competitive scenario
    • 6.4.5.3. Regulatory framework
    • 6.4.5.4. Reimbursement scenario
    • 6.4.5.5. Spain market estimates and forecasts, 2018 - 2030
  • 6.4.6. Denmark
    • 6.4.6.1. Key country dynamics
    • 6.4.6.2. Competitive scenario
    • 6.4.6.3. Regulatory framework
    • 6.4.6.4. Reimbursement scenario
    • 6.4.6.5. Denmark market estimates and forecasts, 2018 - 2030
  • 6.4.7. Sweden
    • 6.4.7.1. Key country dynamics
    • 6.4.7.2. Competitive scenario
    • 6.4.7.3. Regulatory framework
    • 6.4.7.4. Reimbursement scenario
    • 6.4.7.5. Sweden market estimates and forecasts, 2018 - 2030
  • 6.4.8. Norway
    • 6.4.8.1. Key country dynamics
    • 6.4.8.2. Competitive scenario
    • 6.4.8.3. Regulatory framework
    • 6.4.8.4. Reimbursement scenario
    • 6.4.8.5. Norway market estimates and forecasts, 2018 - 2030
• 6.5. Asia Pacific
  • 6.5.1. Japan
    • 6.5.1.1. Key country dynamics
    • 6.5.1.2. Competitive scenario
    • 6.5.1.3. Regulatory framework
    • 6.5.1.4. Reimbursement scenario
    • 6.5.1.5. Japan market estimates and forecasts, 2018 - 2030
  • 6.5.2. India
    • 6.5.2.1. Key country dynamics
    • 6.5.2.2. Competitive scenario
    • 6.5.2.3. Regulatory framework
    • 6.5.2.4. Reimbursement scenario
    • 6.5.2.5. India market estimates and forecasts, 2018 - 2030
  • 6.5.3. China
    • 6.5.3.1. Key country dynamics
    • 6.5.3.2. Competitive scenario
    • 6.5.3.3. Regulatory framework
    • 6.5.3.4. Reimbursement scenario
    • 6.5.3.5. China market estimates and forecasts, 2018 - 2030
  • 6.5.4. South Korea
    • 6.5.4.1. Key country dynamics
    • 6.5.4.2. Competitive scenario
    • 6.5.4.3. Regulatory framework
    • 6.5.4.4. Reimbursement scenario
    • 6.5.4.5. South Korea market estimates and forecasts, 2018 - 2030
  • 6.5.5. Australia
    • 6.5.5.1. Key country dynamics
    • 6.5.5.2. Competitive scenario
    • 6.5.5.3. Regulatory framework
    • 6.5.5.4. Reimbursement scenario
    • 6.5.5.5. Australia market estimates and forecasts, 2018 - 2030
  • 6.5.6. Thailand
    • 6.5.6.1. Key country dynamics
    • 6.5.6.2. Competitive scenario
    • 6.5.6.3. Regulatory framework
    • 6.5.6.4. Reimbursement scenario
    • 6.5.6.5. Thailand market estimates and forecasts, 2018 - 2030
• 6.6. Latin America
  • 6.6.1. Brazil
    • 6.6.1.1. Key country dynamics
    • 6.6.1.2. Competitive scenario
    • 6.6.1.3. Regulatory framework
    • 6.6.1.4. Reimbursement scenario
    • 6.6.1.5. Brazil market estimates and forecasts, 2018 - 2030
  • 6.6.2. Argentina
    • 6.6.2.1. Key country dynamics
    • 6.6.2.2. Competitive scenario
    • 6.6.2.3. Regulatory framework
    • 6.6.2.4. Reimbursement scenario
    • 6.6.2.5. Argentina market estimates and forecasts, 2018 - 2030
• 6.7. MEA
  • 6.7.1. South Africa
    • 6.7.1.1. Key country dynamics
    • 6.7.1.2. Competitive scenario
    • 6.7.1.3. Regulatory framework
    • 6.7.1.4. Reimbursement scenario
    • 6.7.1.5. South Africa market estimates and forecasts, 2018 - 2030
  • 6.7.2. Saudi Arabia
    • 6.7.2.1. Key country dynamics
    • 6.7.2.2. Competitive scenario
    • 6.7.2.3. Regulatory framework
    • 6.7.2.4. Reimbursement scenario
    • 6.7.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030
  • 6.7.3. UAE
    • 6.7.3.1. Key country dynamics
    • 6.7.3.2. Competitive scenario
    • 6.7.3.3. Regulatory framework
    • 6.7.3.4. Reimbursement scenario
    • 6.7.3.5. UAE market estimates and forecasts, 2018 - 2030
  • 6.7.4. Kuwait
    • 6.7.4.1. Key country dynamics
    • 6.7.4.2. Competitive scenario
    • 6.7.4.3. Regulatory framework
    • 6.7.4.4. Reimbursement scenario
    • 6.7.4.5. Kuwait market estimates and forecasts, 2018 - 2030

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company/Competition Categorization
  • 7.2.1. Innovators
• 7.3. Vendor Landscape
  • 7.3.1. List of key distributors and channel partners
  • 7.3.2. Key customers
• 7.4. Global Key company market share analysis, 2024
  • 7.4.1. Koninklijke Philips N.V
    • 7.4.1.1. Company overview
    • 7.4.1.2. Financial performance
    • 7.4.1.3. Product benchmarking
    • 7.4.1.4. Strategic initiatives
  • 7.4.2. GE HealthCare
    • 7.4.2.1. Company overview
    • 7.4.2.2. Financial performance
    • 7.4.2.3. Product benchmarking
    • 7.4.2.4. Strategic initiatives
  • 7.4.3. Baxter (Hillrom Services, Inc.)
    • 7.4.3.1. Company overview
    • 7.4.3.2. Financial performance
    • 7.4.3.3. Product benchmarking
    • 7.4.3.4. Strategic initiatives
  • 7.4.4. AFC Industries, Inc.
    • 7.4.4.1. Company overview
    • 7.4.4.2. Financial performance
    • 7.4.4.3. Product benchmarking
    • 7.4.4.4. Strategic initiatives
  • 7.4.5. SCHILLER AG
    • 7.4.5.1. Company overview
    • 7.4.5.2. Financial performance
    • 7.4.5.3. Product benchmarking
    • 7.4.5.4. Strategic initiatives
  • 7.4.6. EDAN Instruments, Inc.
    • 7.4.6.1. Company overview
    • 7.4.6.2. Financial performance
    • 7.4.6.3. Product benchmarking
    • 7.4.6.4. Strategic initiatives
  • 7.4.7. Medtronic
    • 7.4.7.1. Company overview
    • 7.4.7.2. Financial performance
    • 7.4.7.3. Product benchmarking
    • 7.4.7.4. Strategic initiatives
  • 7.4.8. CONTEC MEDICAL SYSTEMS CO.,LTD
    • 7.4.8.1. Company overview
    • 7.4.8.2. Financial performance
    • 7.4.8.3. Product benchmarking
    • 7.4.8.4. Strategic initiatives
  • 7.4.9. Lepu Medical Technology(Beijing)Co.,Ltd.
    • 7.4.9.1. Company overview
    • 7.4.9.2. Financial performance
    • 7.4.9.3. Product benchmarking
    • 7.4.9.4. Strategic initiatives
  • 7.4.10. Cardioline S.P.A.
    • 7.4.10.1. Company overview
    • 7.4.10.2. Financial performance
    • 7.4.10.3. Product benchmarking
    • 7.4.10.4. Strategic initiatives
• 7.5. Heat Map Analysis/ Company Market Position Analysis
• 7.6. Estimated Company Market Share Analysis, 2024
• 7.7. List of Other Key Market Player